Implementation of the national standardized german medication plan to detect drug related problems: results from the metropolmediplan2016 – mmp16

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-CPS-001
• By: ABBAS, Zahra (Friedrich-Alexander-University Erlangen-Nuremberg, Molecular and Clinical Pharmacy, Erlangen, Germany)
• Co-author(s): Zahra Abbas: Chemistry and Pharmacy, Molecular and Clinical Pharmacy, Erlangen, Germany
  Simone Schächtele: Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology, Erlangen, Germany
  Susanne Schuster: Department of Emergency Medicine , Hospital Fürth, Fürth, Germany
  Martin Sedlmayr: Medical Informatics, Institute for Medical Informatics, Erlangen, Germany
  Frank Dörje: Erlangen University Hospital, Erlangen, Germany
  H. U. Prokosch: Medical Informatics, Institute for Medical Informatics, Erlangen, Germany
  Harald Dormann: Department of Emergency Medicine, Hospital Fürth, Fürth, Germany
  Martin Fromm: Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology, Erlangen, Germany
  Renke Maas: Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology, Erlangen, Germany
  Kristina Friedland: Chemistry and Pharmacy, Molecular and Clinical Pharmacy, Erlangen, Germany
  
• Abstract:

  Background

  A statutory entitlement to a standardized medication plan was established in October 2016 in Germany for all patients, prescribed at least three drugs. is available to FIP members and to congress participants of that specific congress. Please login